In Re RenovaCare, Inc. Securities Litigation

  1. June 04, 2024

    Biotech RenovaCare Can't Beat Investors' Stock Promo Suit

    A New Jersey federal judge has ruled that investors in biotechnology company RenovaCare Inc. failed to prove their case against firms they accused of profiting from a scheme to pump up the company's shares, but otherwise allowed their claims to proceed against the maker of skin burn treatments and a few of its executives.

  2. September 15, 2021

    4 Firms Seek To Lead Biotech Stock Promotion Scheme Suit

    Pomerantz LLP, Hagens Berman Sobol Shapiro LLP, The Rosen Law Firm PA and Glancy Prongay & Murray LLP have launched competing bids to steer investors' two proposed class actions against biotechnology company RenovaCare Inc. in New Jersey federal court over claims the business unlawfully engaged in a stock promotion scheme.